Sabiha Hacibekiroglu, Research Associatehacibekiroglu@lunenfeld.ca
her PhD in Medical Science at the University of Toronto, and has a background in stem cell biology and interdisciplinary research spanning Germany, Canada, and Australia. Her work focuses on developing next-generation cell and gene therapies for retinal diseases. By integrating SafeCell technology with immune-evasive strategies and a novel VEGF “Sticky-Trap” approach, she aims to create minimally invasive, durable, and controllable treatments for age-related macular degeneration (AMD) and beyond. This work is supported by a Fighting Blindness Canada– funded grant, on which she serves as a co-applicant and author. The project has progressed to an initial pre-CTA meeting with Health Canada, reflecting her commitment to advancing these therapies toward clinical application. LinkedIn: https://www.linkedin.com/in/sabiha-hacibekiroglu/
|
